Medicenna Therapeutics Corp (MDNA) Financials
$0.31
$0.00
(0.30%)
As on 03-Jan-2024 09:30EDT
Market cap
$11 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
1.4
Div. Yield
0 %
Cashflow (CA$ Mln) |
TTM | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-12.66
|
-23.58
|
-15.31
|
-8.95
|
-8.04
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
--
|
10.05
|
5.01
|
-15.00
|
-0.35
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
24.76
|
3.88
|
18.26
|
44.28
|
6.82
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (CA$)
|
-0.20
|
0.02
|
-0.41
|
-0.33
|
-0.22
|
-0.17
|
|
|
|
|
|
|
Cash EPS (CA$)
|
--
|
0.02
|
-0.41
|
-0.33
|
-0.22
|
-0.16
|
|
|
|
|
|
|
Adjusted Book Value (CA$)
|
--
|
0.42
|
0.38
|
0.73
|
0.98
|
0.09
|
|
|
|
|
|
|
Dividend per Share (CA$)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash Flow per Share (CA$)
|
--
|
-0.18
|
-0.42
|
-0.29
|
-0.24
|
-0.28
|
|
|
|
|
|
|
Free Cash Flow per Share (CA$)
|
--
|
-0.18
|
-0.42
|
-0.29
|
-0.24
|
-0.28
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
6.15
|
-76.75
|
-46.19
|
-42.80
|
-197.06
|
|
|
|
|
|
|
ROE (%)
|
-53.19
|
6.15
|
-76.79
|
-46.26
|
-42.87
|
-197.06
|
|
|
|
|
|
|
ROA (%)
|
-36.59
|
5.17
|
-68.93
|
-42.82
|
-38.48
|
-98.47
|
|
|
|
|
|
|
EBIT Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Net Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
EBIT Growth (%)
|
-14.09
|
2.95
|
-29.75
|
-109.45
|
-72.88
|
35.69
|
|
|
|
|
|
|
Net Profit Growth (%)
|
-6.41
|
106.83
|
-31.79
|
-106.79
|
-76.49
|
36.94
|
|
|
|
|
|
|
EPS Growth (%)
|
14.82
|
1.05
|
-0.24
|
-0.46
|
-0.36
|
0.46
|
|
|
|
|
|
|
Book Value Growth (%)
|
-36.94
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
--
|
--
|
0.00
|
0.00
|
--
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
--
|
--
|
0.00
|
0.00
|
--
|
|
|
|
|
|
|
Current Ratio
|
7.49
|
9.58
|
8.92
|
10.26
|
20.85
|
2.13
|
|
|
|
|
|
|
Quick Ratio
|
7.49
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Interest Coverage
|
-3.65
|
-1.87
|
-323.19
|
--
|
--
|
--
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Asset Turnover
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Receivable days
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Inventory Days
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Payable days
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
